Lecture 15: Diabetes in Special Populations Flashcards

1
Q

Diabetes in Pregnancy - maternal risk

retinopathy
- dilated eye exam before pregnancy or ___ trimester

pre - ___
- ____ 81-150 mg/day starting at ___ weeks, if no contraindications

A
  • 1st
    eclampsia
  • aspirin, 12-16
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

macrosomia - a baby who’s much larger than avg weight ( > ___ lbs ___ oz)

A

8, 13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Diabetes in Pregnancy - Fetal Risk

  • spontaneous abortion
  • fetal anomalies
  • pre-eclampsia
  • fetal demise
  • macrosomia
  • neonatal ____
  • hyperbilirubinemia
  • neonatal ___ distress syndrome
A
  • hypoglycemia
  • respiratory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

goal A1C pre-conception is < ___ %

A

6.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Glycemic Targets in Pregnancy

  • FBG: ___ - ___ mg/dL
  • 1 hr post prandial: ___ - ___ mg/dL
  • 2 hr post pradial: ___ - ___ mg/dL
  • A1C < ___ %, ideally , ___ % if necessary to prevent hypoglycemia
  • use ___ when possible
A
  • 70-95
  • 110-140
  • 100-120
  • 6%, 7%
  • CGM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Changes to insulin physiology during pregnancy

  • early pregnancy: insulin sensitivity is enhanced and ___ can ensue (especially in pts with type ___ DM)
  • by ___ weeks, insulin resistance increases and total daily insulin dose increases about ___ % per week through week ___
  • may need ___ times pre-prandial
  • insulin requirement levels off in ___ trimester with ___ aging
  • a rapid reduction in insulin requirements may mean development of ___ insufficiency
A
  • hypoglycemia, 1
  • 16 weeks, 5%, 36
  • 2-3
  • 3rd, placental
  • placental
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment in Pts with Diabetes Pre-Pregnancy - Type 1

  • increased risk of hypoglycemia during ___ trimester
  • changes in counterregulatory hormones during pregancy may decrease ___ awarness
  • pregnancy is a ___ state, increasing risk of DKA ( ___ should be prescibed)
  • DKA can increase ___
  • insulin sensitivity ___ with delivery of the placenta and returned to pre-pregnancy levels at ___ weeks
A
  • 1st
  • hypoglycemia
  • ketogenic, ketone test trips
  • stillbirths
  • increases, 1-2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment in Pts with Diabetes Pre-Pregnancy - Type 2

  • BP Target ___ - ___ /____ mmHg
  • pregnancy loss is more common in ___ trimester vs ___ trimester in T1DM
  • often require ___ insulin doses during pregnancy
  • like T1DM, insulin requirements will ___ significanctly after delivery
A

110-135/85
3rd, 1st
high
drop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment in Gestational Diabetes

Insulin is preferred
- starting dose ___ - ___ units/kg/day
- divide dose between basal-bolus insulins

A

0.7-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment in Gestational Diabetes

Metformin can be used if pts cannot take insulin
- ___ the placenta
- may be associated with ___ birth
- if taking for PCOS to induce to induce ovulation, discontinue by end of ___ trimester

A
  • crosses
  • pre-term
  • 1st
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment in Gestational Diabetes

avoid glyburide/glipizide because ___ and birth injury can occur

A

macrosomia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gestational Diabetes Post-Partum

  • GDM associated with increased risk for diabetes at ___ - ___ % after 15-25 years
  • in pts with GDM and prediabetes, lifestyle changes and metformin decrease progression by ___ - ___ % over 10 years

Postpartum
- check OGTT ___ - ___ weeks
- check for diabetes every ___ - ___ years

A
  • 50-75%
  • 35-40%
  • 4-12
  • 1-3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diabetes in Pediatic Populations

T2DM in youth is different from T2DM in adults
- more rapid decline in ___ function
- accelerated development of diabetes complications
- target goals are similar to adults with A1C < ___ %

A
  • B-cell
  • 7%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Diabetes in Pediatic Populations

T1DM
- treatment: ___
- ___ preferred for most pts
- use of ___ important for control

A
  • insulin
  • pump
  • CGM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diabetes in Pediatic Populations

T2DM
- not common for < ___ yo
- A1C < 8.5%: ___ is the initial treatment, based on ___ function
- A1C > or = 8.5, BG > or = ___ mg/dL without acidosis who are symptomatic: ___ + metformin is initial treatment
- if not controlled in both of these, initiate ___
- if not controlled on these 3, inititate ___

A
  • 10 yo
  • metformin, renal
  • 250 mg/dL
  • basal insulin
  • GLP-1
  • bolus insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diabetes in Pediatic Populations - T2DM

GLP-1 may be used in children >/= age ___

the 2 GLP-1s that can be used:

A
  • 10
  • liraglutide
  • exenatide
17
Q

Diabetes in Pediatic Populations - T2DM

if pts present with ketoacidosis, treat with ___ or ___ insulin
- add ___ later

A

SQ, IV
- metformin

18
Q

Diabetes in Pediatic Populations - T2DM

other medications have not been FDA approved in youth, but are being studied (2)

A
  • SGLT2
  • DPP-4
19
Q

Diabetes in older pts

if pts dont have long life expectancy, you dont need to treat aggressively.
- shift focus from A1C to avoiding ___ and ___

A

hypoglycemia, hyperglycemia

20
Q

General Standards of care for hospitals

initiate insulin for glucose >/= ___ mg/dL, then target ___ - ___ mg/dL
- may use a target of ___ - ___ mg/dL or ___ - ___ mg/dL if it can be done without hypoglycemia
- can target glucose > ___ mg/dL in terminally ill pts

A

180 mg/dL , 140-180 mg/dL
- 110-140 mg/dL, 100-180 mg/dL
- 250 mg/dL

21
Q

General Standards of care for hospitals

T or F: tight glycemic control in the hospital has been shown to increase rates of hypoglycemia 10-15 fold, leading to increased mortality

A

True

22
Q

Monitoring of Pts

  • if pt is eating, check ___ readings
  • if pt is not eating, check every ___ hours
  • if pt is on IV insulin, monitor every ___ min to ___ hours
A
  • pre-prandial
  • 4-6 hrs
  • 30 min, 2 hrs
23
Q

T or F: CGM use is not FDA approved for inpatient settings, but becoming more common after COVID

A

True; Dr. Kania said that they are using them bc its easier

24
Q

Treatment

  • ___ is preferred for noncritically ill hospitalized pts along with use of ___ factor
  • use of ___ is discouraged
  • for critical care pts, use ___ insulin
  • in some cases, may be able to continue ___ diabetes medication. metformin or SGLT2s may be held and resumed just before or at discharge
A
  • bolus
  • correction
  • sliding scale
  • non-insulin
25
Q

Hypoglycemia

  • treatment regimens should be altered when glucose falls < ___ mg/dL
  • focus on prevention: dosing errors, timing of doses/eating, ___ leading to hypoglycemia
A
  • 70 mg/dL
  • AKI
26
Q

Glucocorticoids

  • short-acting glucocorticoids like ___, reach peak plasma levels in ___ hours but have effects through out
  • morning dose = ___ during the day, but nighttime levels are nearly back to baseline
  • adjust ___ insulin or add AM ___ dose
  • long-acting glucocorticoids like ___ may mean ___ insulin may need adjustment
A
  • prednisone, 4-6
  • hyperglycemia
  • prandial, NPH
  • dexamethasone, long-acting
27
Q

Perioperative

  • A1C target for elective surgery is < ___ %
  • target BG of ___ - ___ mg/dL during perioperative period, within ___ hours of surgery
  • reduce basal insulin the evening before surgery by ___ %
  • hold all bolus insulin once the patient becomes ___
  • ___ should be held on the day of surgery
  • ___ should be held 3-4 days before surgery
  • hold other oral glucose lowering medications ___ of surgery
  • give half of ___ dose or ___ % of ___ acting insulin or ___ basal insulin, the morning of surgery
  • monitor glucose at least every ___ hours while pt is ___ and dose with ___ acting insulin prn based on correction dosing
A
  • 8%
  • 100-180 mg/dL , 4 hrs
  • 25%
  • NPO
  • metformin
  • SGLT2
  • morning
  • NPH, 75-80%, long, pump
  • 2-4 hrs, NPO, short